These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28766550)

  • 21. Renal insufficiency and failure.
    Dimopoulos MA; Terpos E
    Hematology Am Soc Hematol Educ Program; 2010; 2010():431-6. PubMed ID: 21239831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathogenesis, prevention and treatment of multiple myeloma with peripheral neuritis and renal impairment].
    Li J
    Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):367-9. PubMed ID: 23668216
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal impairment at presentation in multiple myeloma continues to be associated with poor survival.
    Laing AA; Geddes C; Soutar R
    Br J Haematol; 2015 Jun; 169(6):901-2. PubMed ID: 25522297
    [No Abstract]   [Full Text] [Related]  

  • 24. A population-based study of the impact of dialysis on mortality in multiple myeloma.
    Evison F; Sangha J; Yadav P; Aung YS; Sharif A; Pinney JA; Drayson MT; Cook M; Cockwell P
    Br J Haematol; 2018 Feb; 180(4):588-591. PubMed ID: 27766629
    [No Abstract]   [Full Text] [Related]  

  • 25. [Multiple myeloma nephropathy as a cause of renal failure--diagnostic difficulties and prospects for treatment].
    Polak G; Tomczak-Watras W; Nartowicz E
    Pol Arch Med Wewn; 1998 Sep; 100(3):257-61. PubMed ID: 10335031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of multiple myeloma patients presenting with renal failure in a university hospital in the year 2010.
    Suyanı E; Sucak GT; Erten Y; Cakar MK; Ulusal G; Yağcı M; Haznedar R
    Ren Fail; 2012; 34(2):257-62. PubMed ID: 22260636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managing myeloma of the kidney.
    Gertz MA
    Leuk Lymphoma; 2007 Feb; 48(2):221-2. PubMed ID: 17325878
    [No Abstract]   [Full Text] [Related]  

  • 28. Optimizing the treatment of patients with multiple myeloma and renal impairment.
    Grzasko N; Morawska M; Hus M
    Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):187-98. PubMed ID: 25458082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of myeloma-associated renal dysfunction in the era of novel therapies.
    Gaballa MR; Laubach JP; Schlossman RL; Redman K; Noonan K; Mitsiades CS; Ghobrial IM; Munshi N; Anderson KC; Richardson PG
    Expert Rev Hematol; 2012 Feb; 5(1):51-66; quiz 67-8. PubMed ID: 22272706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supportive therapy in multiple myeloma.
    Ludwig H; Zojer N
    Recent Results Cancer Res; 2011; 183():307-33. PubMed ID: 21509692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple myeloma.
    Spitzer TR; Sachs DH; Cosimi B
    N Engl J Med; 2011 Jun; 364(24):2364; author reply 2364. PubMed ID: 21675904
    [No Abstract]   [Full Text] [Related]  

  • 32. [Achievement of hemodialysis discontinuation with lenalidomide and dexamethasone therapy in a refractory BJP-type multiple myeloma patient].
    Uchida T; Inoue M; Hua J; Hagihara M
    Rinsho Ketsueki; 2016 May; 57(5):613-7. PubMed ID: 27263787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical characteristics of multiple myeloma with renal impairment and the efficacy of different treatments].
    Liu Y; Ke X; Wang J; Wang Y; Wan W; Zhang W
    Zhonghua Xue Ye Xue Za Zhi; 2014 Sep; 35(9):842-4. PubMed ID: 25246256
    [No Abstract]   [Full Text] [Related]  

  • 34. Renal Insufficiency in newly-diagnosed multiple myeloma: analysis according to International Myeloma Working Group consensus statement.
    Park S; Han B; Kim K; Kim SJ; Jang JH; Kim WS; Jung CW
    Anticancer Res; 2014 Aug; 34(8):4299-306. PubMed ID: 25075062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognosis of concurrent renal impairment at diagnosis of multiple myeloma: a systematic review.
    Zhang Y; Pan J; Kang H; Peng S; Tung TH; Shen B
    Ann Med; 2024 Dec; 56(1):2380301. PubMed ID: 39034813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of acute renal failure due to myeloma kidney.
    Bear RA; Cole EH; Lang A; Johnson M
    Can Med Assoc J; 1980 Oct; 123(8):750-3. PubMed ID: 7004618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis and treatment in complication of multiple myeloma].
    Hou J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 38(5):437-8. PubMed ID: 19830853
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma.
    Dimopoulos MA; Roussou M; Gkotzamanidou M; Nikitas N; Psimenou E; Mparmparoussi D; Matsouka C; Spyropoulou-Vlachou M; Terpos E; Kastritis E
    Leukemia; 2013 Feb; 27(2):423-9. PubMed ID: 22763386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current approach to diagnosis and management of acute renal failure in myeloma patients.
    Leung N; Behrens J
    Adv Chronic Kidney Dis; 2012 Sep; 19(5):297-302. PubMed ID: 22920640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Managing renal complications in multiple myeloma.
    Fotiou D; Dimopoulos MA; Kastritis E
    Expert Rev Hematol; 2016 Sep; 9(9):839-50. PubMed ID: 27426872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.